Evolutionary non-linear modelling for selecting vaccines against antigenically variable viruses by Rahman, T et al.
BIOINFORMATICS Vol. 00 no. 00 2013Pages 1–8
Evolutionary Non-linear Modelling for Selecting Vaccines
Against Antigenically-variable Viruses
Tameera Rahman 1, Mana Mahapatra 2, Emma Laing 3,∗ and Yaochu Jin 1,∗
1Department of Computing, University of Surrey, Guildford, GU2 7XH, United Kingdom.
3The Pirbright Institute, Pirbright, GU24 0NF, United Kingdom.
2Department of Microbial and Cellular Sciences, University of Surrey, Guildford, GU2 7XH, United
Kingdom.
Received on XXXXX; revised on XXXXX; accepted on XXXXX
Associate Editor: XXXXXXX
ABSTRACT
Motivation: In vitro and in vivo selection of vaccines is time consu-
ming, expensive and the selected vaccines may not be able to provide
protection against broad-spectrum viruses because of emerging anti-
genically novel disease strains. A powerful computational model that
incorporates these protein/DNA or RNA level fluctuations can effe-
ctively predict antigenically variant strains, can minimise the amount
of resources spent on exclusive serological testing of vaccines and
make wide spectrum vaccines possible for many diseases. However,
in silico vaccine prediction remains a grand challenge. To address the
challenge, we investigate the use of linear and non-linear regression
models to predict the antigenic similarity in foot-and-mouth disease
virus strains and in influenza strains, where the structure and para-
meters of the non-linear model are optimised using an evolutionary
algorithm. In addition, we examine two different scoring methods
for weighting the type of amino acid substitutions in the linear and
non-linear models. We also test our models with some unseen data.
Results: We achieved the best prediction results on three data sets
of SAT2 (Foot-and-Mouth disease), two data sets of serotype A (Foot-
and-Mouth disease) and two data sets of influenza when the scoring
method based on biochemical properties of amino acids is employed
in combination with a non-linear regression model. Models based on
substitutions in the antigenic areas performed better than those that
took the entire exposed viral capsid proteins. A majority of the non-
linear regression models optimised with the evolutionary algorithm
performed better than the linear and non-linear models whose para-
meters are estimated using the least squares method. In addition,
for the best models, optimised non-linear regression models consist
of more terms than their linear counterparts, implying a non-linear
nature of influences of amino acid substitutions. Our models were
also tested on five recently generated FMDV datasets and the best
model was able to achieve an 80% agreement rate.
1 INTRODUCTION
Vaccines can be effective in preventing viral diseases and impro-
ving the health of millions. However, there are many viral diseases
for which vaccine production/deployment is a challenge because of
∗To whom correspondence should be addressed. Email: {yaochu.jin,
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extensive antigenic variability1. Infection and/or vaccination by an
antigenically-variable virus does not necessarily confer protection
to subsequent exposure of the disease, e.g., Human Immunodefi-
ciency Virus (HIV), Influenza and Foot and Mouth Disease Virus
(FMDV) (Moxon and Siegrist, 2011). Hence, upon an outbreak of
an antigenically-variable virus, a rapid response to reduce the spread
of the virus is needed. In other words, the rapid selection of the most
effective vaccine, against the particular strain of virus, is impera-
tive. However, the in vitro serological tests that measure the cross
reactivity of vaccines to outbreak-strains are time consuming and
expensive. An in silico predictor that can accurately predict vaccine
efficacy would be invaluable.
With the advent of high-throughput sequencing, it is now pos-
sible to obtain the sequence of a virus within hours. The com-
putational exploitation of this sequence information for vaccine
design/selection is therefore attractive. Yet to date, most computati-
onal research on viral vaccines has focussed on developing tools for
identifying epitopes (Meister et al., 1995; Schafer et al., 1998; Bru-
sic et al., 1994; De Groot et al., 2002). From our literature search,
only three previous studies attempting to predict antigenic variabi-
lity and therefore vaccine efficacy, for Foot and Mouth Disease and
Influenza were identified (Reeve et al. (2010); Liao et al. (2008);
Reeve et al. (2011)). Foot and Mouth Disease and Influenza are both
socio-economically important, highly infectious diseases caused by
antigenically-variable viruses. As DNA sequences and associated
serological test data are available for these viruses, they are obvi-
ous candidates for the development of an in silico vaccine selection
predictor.
Thus far, in silico approaches for predicting vaccine efficacy have
focussed on the use of linear and logistic regression techniques
(Reeve et al. (2010) used linear mixed effects models to relate esti-
mated antigenic differences to sequence variation in FMDV and
Liao et al. (2008) used stepwise and logistic regression to predict
antigenic variants in Influenza). However, as vaccine efficacy relies
on the interaction of amino acid residues within or outside an anti-
genic site (loop) (Lesk, 2001) that may result in unusual (non-linear)
patterns in antigenic distance (Lee and Chen, 2004) it is likely
1 Antigenic variability is the mechanism by which infectious organisms
(bacteria, virus or protozoa) alters its surface protein to evade a host immune
system (Daintith, 1990)
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that non-linear models, that can handle complex interdependencies
between variables, will be better suited. Furthermore, as biological
data can be noisy and/or viral strains partially labelled (dataset con-
tains only sequence data but not serological data) (Bandyopadhyay,
2007; Li, 2010), a predictor that can be trained with imperfect data
is needed.
Here we present a Genetic Algorithm (GA) optimised quadratic
non-linear regression model that is able to accurately (98 % accu-
racy)predict the vaccine efficacy for Foot and Mouth Disease Virus
(FMDV) and Influenza A strains taking amino acid sequences as
input. We show that our model is an improvement to the approaches
previously taken. Furthermore, to examine whether there are dif-
ferences in the influence of amino acid changes in different capsid
proteins on the Virus Neutralisation (VN) titre/Haemagglutination
inhibition (HI) assay value we compare two approaches for calcula-
ting amino acid changes, one reporting the total number of changes
across all capsid proteins (three capsid proteins in FMDV and one
in influenza), while the other reporting specific-capsid changes.
Finally, we study two methods for weighting the importance of
amino acid changes, one based on the characteristics and structure
of amino acids and the other based on amino acid substitution scores
(PAM/BLOSUM).
2 METHODS
2.1 Data
Three datasets comprising serological and amino acid sequence data
for outbreak-vaccine strain pairs for three different viruses were
used to train and cross-validate our models: (1) 22 FMDV SAT2
outbreak-vaccine strain pairs, taken from Reeve et al. (2010); (2) 52
outbreak-vaccine strain pairs for FMDV A, taken from Upadhyaya
et al. (2013); and (3) 54 outbreak-vaccine strain pairs for Influenza
A H3N2, taken from Liao et al. (2008).
Amino acid sequences for FMDV and Influenza A were either
downloaded from GenBank or provided by The Pirbright Institute.
The sequences of a particular viral serotype were harmonised to
the same length (669 residues for SAT2 comprising viral proteins
(VP) 1-3, 655 residues for A similarly comprising (VP) 1-3 and 329
residues for HA1 gene of H3N2) by obtaining a multiple sequence
alignment using ClustalW (Thompson et al., 2002). This alignment
was used to identify substitutions between the pairs of sequences for
which the serological data was available. We have used two different
approaches to build the models. In one we have used substitutions
only from specific antigenic regions, two regions in VP1 and one in
VP2 (Reeve et al., 2010) for FMDV (SAT2 and A) and three regions
in H3N2 HA1 (Lee et al., 2007). In the other setup, we have used
substitutions in all three capsid proteins (VP1, VP2 and VP3) for
SAT2 and A, and the entire HA1 sequence for H3N2.
2.2 Scoring Methods
Scoring methods are used to determine the difference between a
pair of aligned amino acid sequences. Using our models we com-
pared three different scoring methods: 1)“No weighting”: the basic
approach of counting the number of substitutions between a pair
of aligned sequences, as previously applied in studies on FMDV
(Reeve et al., 2010). 2) “Grouping” : a weighting method applied in
studies on Influenza A (Liao et al. (2008)). The 20 amino acids are
Fig. 1: Flowchart of our study.
divided into seven groups, namely, non-polar aliphatic, non-polar
aromatic, polar, positively charged and negatively charged and sub-
stitutions between groups are assigned 1 while those within a group
are assigned 0.
3)“Matrix Scoring”: Use of the PAM-120 matrix, a matrix scoring
the probability with which one amino acid is substituted by another
in closely related species (Dayhoff, 1978). The matrix was modified
by setting the diagonal values to 0 so that identical amino acids in the
two sequences are not scored. The positive values were changed to
zero and the negative values to positive so that frequently occurring
substitutions are not scored while the rare substitutions are scored.
In addition, all elements in the matrix were normalised between 0
and 0.5. The scores using this approach were calculated by totalling
the values of all elements corresponding to substitutions between
pairs of sequences.
2.3 Linear and Non-linear Prediction
Linear and non-linear models were constructed to predict the anti-
genic variability. The scoring methods described above were used as
the continuous dependent variables for prediction using regression
techniques.
2.3.1 Linear Regression Model Linear regression is the most
widely used regression technique. It aims to find the best line that
fits the data. When the amino acid changes in all capsid proteins are
totalled, the linear model has only one dependent variable x, and the
predicted VN titre or HI assay value (y) can be predicted as follows:
y = β0 + β1x. (1)
When changes are calculated for specific antigenic regions there
are three dependent variables (x1, x2, x3), and the linear regression
model for predicting the VN titre or HI assay value has the following
form:
y = β0 + β1x1 + β2x2 + β3x3, (2)
where β0, β1, β2 and β3 are the regression coefficients that need
to be estimated. The parameters are estimated by minimising the
mean squared error (MSE) between the experimental and the pre-
dicted values (Friedman et al., 2001), which is known as the least
squares method (LSM).
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2.3.2 Non-linear Regression Models In the linear regression
model, it is assumed that the VN titre or HI assay value depends
linearly on the amino acid changes. However, this may be overly
simplistic and not adequate for describing the relationship betw-
een the VN titre or HI assay value and the amino acid changes. A
non-linear regression model, however, can describe a more complex
relationship between the dependent (VN titre or HI assay value) and
the independent variables (amino acid changes). Here, we adopted a
quadratic (second-order polynomial) non-linear regression model.
Similar to that described for linear models, there is one depen-
dent variable if the amino acid changes in the capsid protein(s) are
totalled, and three variables if the amino acid changes are counted
specifically for each of the antigenic regions (capsid proteins). In
the former case, the quadratic model is in the following form:
y = β0 + β1x+ β2x
2
, (3)
and in the latter case, the quadratic model has the following form:
y = β0 + β1x1 + β2x2 + β3x3
+β4x1x2 + β5x1x3 + β6x2x3
+β7x
2
1 + β8x
2
2 + β9x
2
3. (4)
where βi, i = 1, 2, ..., 9 are the regression coefficients to be deter-
mined. Typically, these parameters can also be estimated using the
least squares method.
In this work, we not only want to estimate the coefficients in the
quadratic regression model, but also to examine if any of the terms
in the non-linear model in Equation (4) can be removed to reduce
the complexity of the model. This is potentially beneficial due to
the small number of experimental data available for determining the
coefficients. In the following, we describe in more detail a method
for optimising the structure and coefficients of the quadratic regres-
sion model using an evolutionary algorithm, specifically a hybrid
genetic algorithm.
2.3.3 A Hybrid Genetic Algorithm Evolutionary algorithms
(EAs) were first developed in the early 1960s as models that simu-
late biological evolutionary processes for parameter optimisation
(Back et al., 1997), among other purposes. GAs (Goldberg, 1989)
and evolution strategies (Schwefel, 1995) are two classes of widely
used EAs for optimisation.
GAs were introduced in 1975 by J.Holland (Holland, 1992).
A canonical GA uses binary (or Gray) coding for representing
the decision variables to be optimised. Starting from a randomly
generated parent population, in which each individual represents
a candidate solution, a canonical GA performs crossover and flip
mutation to generate new candidate solutions (offspring). The off-
spring individuals are then evaluated to determine their fitness, and
in this work, the prediction error of each candidate model. Then,
offspring individuals are selected according to their fitness value as
parents for the next generation. In this work, the better the fitness
value (i.e., the smaller the prediction error), the more likely an off-
spring individual will be selected. The selection process simulates
the principle of survival of the fittest in natural evolution. This gene-
rations cycle continues until a termination criteria is fulfilled, e.g.,
when the predefined number of generations have been processed.
Many variants of the canonical GA have been developed by intro-
ducing new representation schemes, genetic variations and selection
methods to enhance the search performance of the canonical genetic
algorithms, see e.g. (Back et al., 1997). For example, in real-coded
GAs (RCGAs), decision variables can be directly represented using
real-values (Deb and Agrawal, 1995). Accordingly, new crosso-
ver and mutation operators, e.g., simulated binary crossover (SBX)
and new mutation operators such as polynomial mutation have been
designed for RCGAs (Deb and Agrawal, 1995).
Simulated binary crossover (SBX) operation was proposed by
(Deb and Agrawal, 1995). Given two parent solutions x(1,t)i and
x
(2,t)
i , a random number, ui, between 0 and 1 is generated at first:
βqi =


(2ui)
1
ηc+1 if ui ≤ 0.5(
1
2(1−ui)
) 1
ηc+1
otherwise,
(5)
where ηc is a distribution index. As recommended in Deb and Agra-
wal, 1995, ηc is typically set to 20. Two offspring solutions, x(1,t+1)i
and x(2,t+1)i , are then produced as follows:
x
(1,t+1)
i = 0.5
[
(1 + βqi) x
(1,t)
i + (1− βqi) x
(2,t)
i
]
, (6)
x
(2,t+1)
i = 0.5
[
(1− βqi) x
(1,t)
i + (1 + βqi) x
(2,t)
i
]
, (7)
In polynomial mutations, a probability distribution is first defined:
P (βmi) = 0.5 (ηm + 1) (1− |βmi|)
ηm , (8)
where ηm is the distribution factor, and βmi is given by,
βmi =
{
(2ui)
1
ηm+1 − 1 if ui ≤ 0.5
1− (2 (1− ui))
1
ηm+1 otherwise ,
(9)
If a mutation in the individual occurs, the parameter value is given
as
x
′ = x+ (α− δ)βmi , (10)
where α and δ are the upper and lower bounds for the mutation
values respectively. ηm is also set to 20 in this work. Additional
details of both the SBX and polynomial mutation operations can be
found in (Deb and Agrawal, 1995).
We use a hybrid genetic algorithm to optimise both the structure
as well as the parameters of quadratic regression model in Equa-
tion (4). By structure, we mean here which of the 10 terms in the
non-linear model should be kept for prediction. We aim to find
a quadratic model of minimum complexity that best predicts the
SAT2,A and H3N2 data. Meanwhile, we intend to optimise the coef-
ficients of the existing terms in the non-linear regression model.
In the following, we elaborate the details of the hybrid genetic
algorithm used for optimising the non-linear regression model.
Representation: A binary chromosome and a real-valued chro-
mosome are used to represent the structure and coefficients of the
non-linear regression model, respectively. The binary chromosome
has 10 bits of a value ‘0’ or ‘1’, where a ‘1’ means that the cor-
responding term of the model in Equation (4) is kept in the model
and a ‘0’ indicates that the corresponding term is deleted. The real-
valued chromosome directly encodes the coefficients. For example,
the following individual
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1 0 0 0 1 0 1 0 0 1
0.1 1.2 -1.5 0.5 2.2 0.3 -0.8 0.1 1.8 3.2
defines the following non-linear regression model:
y = 0.1 + 2.2x1x2 − 0.8x2x3 + 3.2x
2
3. (11)
Population: In this work, the population size is set to 100,
with each individual representing a candidate non-linear regression
model specified by two chromosomes. The initial parent population
is generated randomly, the value of the binary chromosome is set to
‘0’ or ‘1’ with a probability of 0.5, respectively, whereas the value of
the real-valued chromosome is set to a uniformly distributed random
number between [-0.1, 0.1].
Fitness function: The fitness of the individuals is determined by
calculating the MSE between the predicted and the experimental VN
titre or HI assay values:
MSE =
1
N
N∑
i=1
(
yi − y
d
i
)2
, (12)
where yi and ydi are the VN titre or HI assay value predicted by
the model and the experimental value of the i-th training data pair,
respectively, i = 1, 2, ..., N , N is the number of training samples.
The selection strategy adopted in this work is an elitism stra-
tegy. Before selection, the offspring population is combined with the
parent population, forming a population of 200 individuals. Then,
the best 100 individuals are selected as the parents for the next
generation.
Reproduction: The binary tournament selection is adopted to
select individuals from the parent population to generate offspring,
one at a time. At each time, two individuals in the parent population
are randomly selected and the fitter is chosen as a parent. This is
repeated to choose a second parent individual.
Crossover and mutation are then applied to the two parents to
generate two offspring individuals. As each individual has two
different types of chromosomes, different crossover and mutation
operators are applied to the binary and real-valued chromosomes.
For the binary chromosome, uniform crossover and flip mutations
are employed. For the real-valued chromosome, SBX and polyno-
mial mutation are used. The probability for crossover and mutation
are specified to be 0.9 and 1, respectively. This process repeats until
100 offspring are generated.
Selection: Parent populations are combined with the offspring
population before selection. The 200 individuals are sorted based
first on the individuals’ front number in a decreasing order and then
on the crowding distance in an ascending order. Finally, the first 100
individuals are selected as the parents of the next generation. In this
work, 500 generations are run before the evolutionary optimisation
is terminated.
2.4 Model Performance Comparison
The specificity, sensitivity and agreement rates for pairs of predicted
and true VN titre or HI assay values were calculated for all models.
For FMDV serotype SAT1 and A r1 values between 0.3 and 1.0
are indicative of reasonable levels of cross protection, whilst values
below 0.3 indicate the need to acquire or develop a new/different
vaccine strain (Barnett et al., 2001). Specificity is the ratio of the
predicted similar viruses (predicted VN titre or HI assay value >
0.3) to the true similar viruses (actual VN titre or HI assay value
> 0.3) as a percentage. Sensitivity is the ratio of predicted variants
(predicted VN titre or HI assay value < 0.3) to true variants (actual
VN titre or HI assay value < 0.3) represented as a percentage. The
agreement rate is the ratio of all truly predicted pairs to the number
of all virus pairs. In addition to the above performance parameters,
the MSEs were also compared for all models. In addition to the
above performance parameters, the MSEs were also compared for
all models.
3 RESULTS AND DISCUSSIONS
Figure 1 provides an overview of our approach. Here we assume
that the efficacy (cross-reactivity) of a vaccine is accurately measu-
red by a serological test (HI for Influenza or VN for foot and mouth
disease) and that this can be predicted from the alignment of amino
acid sequences for the heterologous virus (e.g. outbreak strain) and
homologous virus (e.g. the vaccine strain) pair. Thus, to create
our training and validation data sets we use serological test results
(r1/HI assay values) and the sequence data from the alignment files.
The serological data results are directly used as the dependent vari-
ables for regression analysis while the sequence data from pairwise
comparisons are used with three types of scoring methods (refer to
Table 2.2 for details), outputs of which are used as the independent
variables for regression analysis.
In the following we compare the prediction performance of the
linear and non-linear regression models, where in one case the
amino acid changes on the capsid protein(s) are totalled (herein
referred to as ‘no loops’), and in the other case, the changes in
the three antigenic regions are counted separately (referred to as
‘loops’). The agreement rates for the two FMDV serotypes SAT2,
A and influenza A are shown in Table 1. The MSEs for the same
datasets are presented in Figures 2, 3 and 4 respectively. From the
figures, we can see that better prediction results can be achieved
when the amino acid changes in different capsid proteins are treated
as different independent variables. The agreement rates for models
with immunodominant positions (a total of 39) or ‘loops’ were at
least similar or better than those containing amino acid positions
for the capsid protein(s). In addition, the MSEs for the models with
antigenic loops are lower than those without loops except the “sco-
ring model”, whose MSEs are almost the same, refer to Figures 2,
3 and 4. It is noteworthy that the non-linear grouped model opti-
mised using the GA obtained the best performance. The results
from the three datasets for FMDV SAT 2, two datasets for FMDV
A and two datasets for influenza are consistent across serotypes.
SAT2 results presented here are for SAT2 sequence RWA/2/01, A
sequence TUR02 and influenza Phyllipines/02/82/01.
Even though the capsid protein(s) are directly involved in deter-
mining the antigenicity of the virus, from the modelling point of
view, it is only the specific antigenic areas (loops) that are most
relevant. However, when the changes in capsid(s) are summarised,
useful information for prediction purposes may be lost, resulting in
poor prediction performance. Indeed, certain positions within the
capsid proteins, not included in the antigenic loops may be essen-
tial for improving the prediction quality. Thus a way to weigh each
position to extract the most significant ones will greatly improve the
model based on antigenically relevant residues.
When we compare scoring methods, the grouping method per-
forms the best out of the three. The grouping method had agreement
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rates between 73% and 100% while the matrix scoring method
between 26% and 85%. For the non-weighted approach, it was
between 62% and 90% across all datasets. The lower rates corre-
spond to models involving residues in the capsid protein(s). Table 1
shows the performance of the weighted and the non-weighted linear
and non-linear models.
The grouping method that classifies amino acids based on their
biochemical properties distinguishes between amino acid substituti-
ons based on their relevance to the overall protein structure and thus
would be expected to enhance the regression models. The 20 amino
acids have different properties and not all substitutions are equally
important for measuring antigenic variability. It is also known that
certain amino acid substitutions are more common than others (Betts
and Russell, 2003).
We also carried out some correlation analysis for the type of
amino acid substitutions and antigenic similarity between virus. We
found that some commonly occurring substitutions have no corre-
lation or are slightly positively correlated to antigenic similarity.
Pearson’s correlation coefficient for T-A/A-T and S-A/A-S substitu-
tions is 0.179 and 0.312, respectively. The correlation obtained was
weak due to the limited amount of data available for the analysis.
This is contrary to the expectation that the number of amino acid
substitutions must be negatively correlated to antigenic similarity.
However, for some less frequently occurring substitutions the corre-
lation was seen to be weakly negative. This is explained by the fact
that, in nature, substitutions of one amino acid with another of simi-
lar properties is permissible, with the overall structure/function of
the protein remaining unchanged (Chasman and Adams, 2001). The
grouping method exploits this phenomenon by scoring substitutions
with similar biochemical properties as 0 and substitutions that may
change the structure and/or functions of the resultant proteins as 1.
The non-weighted approach that considers all substitutions regard-
less of structural relevance, includes frequent substitutions that are
of little significance to the model; the overall result of this is a poor
quality model.
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Fig. 2: The MSEs of the linear and non-linear regression models
using different weighting methods for antigenic regions and whole
capsid proteins for FMDV serotype SAT2. Key: L-with loops,
NL-no loops, NW-Non-weighted, G-grouped, MS-matrix scored.
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Fig. 3: The MSEs of the linear and non-linear regression models
using different weighting methods for antigenic regions and whole
capsid proteins for FMDV serotype A. Key: L-with loops, NL-no
loops, NW-Non-weighted, G-grouped, MS-matrix scored.
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Fig. 4: The MSEs of the linear and non-linear regression models
using different weighting methods for antigenic regions and whole
capsid proteins for influenza A. Key: L-with loops, NL-no loops,
NW-Non-weighted, G-grouped, MS-matrix scored.
Comparing the performance of the nonlinear regression model
with LSM and the one optimised with GA, we found from Figs. 2
to 4 and Table 1 that the GA model perform clearly better in 12 out
of 18 cases, while the GA model is worse than the LSM model only
in three cases. In addition, it is noted that the agreement rates on
the FMDV A dataset are slightly worse than those of the other two
datasets. This might be attributed to the fact that the spread of the r1
values in the FMDV SAT2 and INFLUENZA datasets is better than
that in the FMDV A dataset.
However, the performance of the non-linear models was consi-
stently better than the linear models across all virus datasets, scoring
methods and antigenic regions (i.e, loops/non-loops). Eqs. (13) and
(14) detail are the two best performing quadratic models; a grouped
with loops and a non-weighted with loops model, respectively for
SAT2.
f(x) = 0.09 + 0.07x1 + 0.09x2 + 0.03x1x2 − 0.07x2x3
− 0.03x21 + 0.09x
2
2 − 0.06x
2
3. (13)
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Table 1. Performance results of different linear and non-linear models for FMDV and influenza data. Key: Sn-Sensitivity, Sp-Specificity, Agg. rate-Agreement
rate, No. of coef(no. sig)-No. of model coefficients(no. of significant coefficients), LR-Linear regression, NLR-Non-linear Regression, GA-Genetic algorithms,
LS-Least Squares, NL-Non-weighted looped, N-NL-Non-weighted no loop, G-L-Grouped looped, G-NL-Grouped no loop, MS-L-Matrix scored looped,
MS-NL-Matrix scored no loop.
Analysis Weighting FMDV SAT2 (N=22) FMDV A (N=52) INFLUENZA (N=54)
No. of
coef(no.
sig)
Sn Sp Ag rate No. of
coef(no.
sig)
Sn Sp Ag rate No. of
coef(no.
sig)
Sn Sp Ag rate
LR NW-L 3(2) 100 80 62 3(2) 60 70 70 3(1) 50 57 63
NW-NL 3(3) 0 100 78 0 4 90 65 4(3) 20 76 79
G-L 4(3) 80 100 80 4(2) 100 80 75 4(3) 100 75 75
G-NL 2(2) 50 90 77 3(2) 20 80 60 3(2) 25 75 70
MS-L 4(2) 25 90 80 3(1) 0 100 68 2(2) 33 77 75
MS-NL 4(3) 25 90 30 4(2) 25 100 55 2(0) 0 11 30
NLR NW-L 10(6) 100 80 70 10(6) 80 75 84 10(7) 55 50 70
with LS NW-NL 10(5) 0 100 79 10(5) 0 77 70 10(6) 20 66 73
G-L 10(8) 100 100 98 10(6) 100 78 80 10(7) 100 75 95
G-NL 10(6) 50 75 78 10(5) 20 78 68 10(5) 44 75 68
MS-L 10(6) 0 100 82 10(6) 0 100 75 10(5) 50 50 80
MS-NL 10(7) 25 90 35 10(6) 25 100 70 10(4) 0 10 35
NLR NW-L 7(6) 100 80 74 8(7) 85 75 84 5(3) 50 66 75
with GA NW-NL 2(2) 0 100 80 4(2) 0 75 67 5(3) 20 75 73
G-L 6(6) 100 100 100 7(6) 100 100 100 7(7) 100 100 100
G-NL 3(3) 55 81 77 4(2) 0 100 80 5(4) 55 75 70
MS-L 9(6) 0 100 83 8(7) 0 100 75 9(7) 53 66 85
MS-NL 6(3) 25 90 37 7(4) 25 100 35 6(3) 0 15 37
f(x) = 0.07− 0.01x1 + 0.07x2 + 0.006x3 + 0.05x1x2
− 0.002x1x3 − 0.06x2x3 + 0.0865243x
2
2 − 0.1x
2
3. (14)
These regression models have a much larger number of terms than
their linear counterparts. In other words, the non-linear models have
a much higher complexity than that of the linear models. In cases
where the GA-optimised non-linear regression models have perfor-
med worse than the linear models, the non-linear models are found
to be much simpler (fewer number of coefficients), refer to Table 1.
We also calculated the 95% confidence interval for all model coef-
ficients to find out the statistically significant ones which supports
the above and are also reported in the same table. This implies that
the relationship between the variables may be highly non-linear and
there is a complex additive effect of two or more types of amino acid
substitutions, which can be better explained by quadratic terms.
We carried out a null hypothesis test to see whether our best model
(non-linear regression with GA using the grouped looped scoring
method) performed better than the linear, non-linear regression with
LS and cubic models using the same scoring methods. For the linear
model, the r2 (coefficient of determination of the regression line)
was 0.186 and p value (probability of obtaining the observed sam-
ple results when the null hypothesis is actually true) was 0.10. For
the non-linear model with LS r2 was 0.326 and p was 0.05; for the
cubic model r2 was 0.467; p was 0.02. However, for our non-linear
model with GA r2 was 0.787; p was 0.0002. The above results show
that even though there are improvements in both r2 and p values
from one to the next higher degree model, our method using a qua-
dratic model with GA performs better than a cubic model. Thus we
can confidently reject the null hypothesis that our non-linear regres-
sion with GA does not perform better than the linear and the cubic
models.
We also used five additional pairwise comparisons of FMDV
A sequences (provided by The Pirbright Institute) to test our best
model (grouping method with non-linear regression using GA). The
model was able to achieve an 80% agreement rate with the actual
serological data. Both the non-linear using LS and the linear models
achieved 60% agreement rate on the actual data. It was generally
seen that the sequences for which the test results did not match the
actual serological data, the input variables for testing were outside
the range of the data that was used for training the models. Consequ-
ently, we think that the availability of more data for training would
have helped us achieve better agreement rates to the actual data.
Table 2 gives a summary of the results. These results are highly
encouraging, considering that only very limited amount data was
available for training the models. Our results clearly indicate that
nature-inspired optimisation techniques are competitive for solving
challenging biological problems.
Although our test results indicate that a cubic regression model
may not necessarily better than the quadratic model, it is still of
interest to investigate whether more general models, which can be
created using symbolic regression with the help of genetic program-
ming Schmidt and Lipson (2009), in particular if there is more data
available.
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Table 2. Comparison of predicted and actual r1 values using our grouping
method with the three types of regression models. Key: St 1-Reference strain
1 (IRQ/24/64), St 2-Reference strain 2 (TUR/20/06).
Challenge Model Predicted Actual
Strain St 1 St 2 St 1 St 2
IRN/07/13 NLR with
GA
0.17 0.29 0.15 0.25
NLR with
LS
0.11 0.15
LR 0.09 0.16
IRN/35/12 NLR with
GA
0.15 0.39 0.18 0.45
NLR with
LS
0.18 0.22
LR 0.08 0.18
TUR/05/12 NLR with
GA
0.53 0.25 0.24 0.28
NLR with
LS
0.32 0.44
LR 0.15 0.36
IRN/01/13 NLR with
GA
0.20 0.29 0.095 0.221
NLR with
LS
0.30 0.15
LR 0.21 0.40
SAU/23/86 NLR with
GA
0.56 0.11 0.1 0.14
NLR with
LS
0.22 0.17
LR 0.46 0.02
CONCLUSIONS
This study compared three types of regression models, namely,
linear, quadratic with parameter optimisation using LSM, and qua-
dratic with both the structure and parameters being optimised with
a hybrid GA. All of these models were further compared based
on the presence/absence of specific antigenic loops for FMDV and
influenza. The looped models performed ∼ 20% better than the
unlooped models. Better prediction results are achieved when amino
acid changes in the capsid(s) were treated as different independent
variables. Models with substitutions in the antigenic areas per-
formed better than ones that took the entire exposed viral capsid
protein(s) i.e. only the specific antigenic regions on the capsid pro-
tein(s) are most relevant for modelling. When substitutions in the
capsid(s) are summarised, important information for prediction may
be overlooked resulting in poor results. MSEs for looped models
are lower than their unlooped counterparts except the scoring model
for which the MSEs are almost the same. Comparing the weighted
and the non-weighted methods, the grouping method performed best
among the three, which is probably because the grouping method
classifies amino acids based on their biochemical properties that
enhances the models. The non-weighted approach did not perform
as well as the grouping method perhaps because it considers all
substitutions regardless of structural relevance, thereby including
frequent substitutions of little significance to the model. The pre-
diction power of the scoring method was unexpectedly low which
is probably because a significant amount of biological data was lost
when the substitution matrix was normalised to penalise only the
non-frequent substitutions. Overall, the models that combined the
scoring method based on biochemical properties of amino acids with
non-linear regression for the specific antigenic areas on the capsid
protein(s) gave best results.
We used a GA to optimise the structure and parameters to fit
the non-linear model. GA is a much more robust optimisation
method than LSM as LSM cannot find the optimal solution of
coefficients if the initially guessed solution is not sufficiently close
to the ideal solution. Hence, GAs are able to work well with
noisy biological data, which is reflected in our results as the non-
linear regression models using the GA performed consistently better
(throughout datasets) than the linear and the non-linear models
whose parameters are estimated using the LSM.
The predictive ability of any model heavily depends on the data
used to build them. Thus the quality and availability of data has a
profound effect on the efficiency and the predictive ability of the
method. Consequently, due to lack of serological data, the results
reported in this paper are still preliminary. Nevertheless, conside-
ring that we have achieved similar results across six datasets for two
different viruses (FMDV and influenza), it would not be unreasona-
bly optimistic to say that similar models can perhaps be deployed for
other viruses when working towards developing an in silico vaccine
predictor.
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